Comparison of Sinonasal Histopathological Changes in Biological Treatment of Eosinophilic Chronic Rhinosinusitis.

Jacqueline HoRaquel AlvaradoJanet RimmerWilliam A SewellSophie WalterPeter EarlsRaewyn G CampbellRaymond SacksLarry H KalishRichard J Harvey

Published in: American journal of rhinology & allergy (2021)

Tissue histopathologic outcomes reflect the differing mechanism of action of mepolizumab and benralizumab in eCRS. Further analysis at the tissue level will provide further information to guide application of mAbs in type 2 inflammatory diseases.

Keyphrases

chronic rhinosinusitis
oxidative stress
metabolic syndrome
smoking cessation
weight loss
data analysis